Literature DB >> 20305534

Cellular angiofibroma with atypia or sarcomatous transformation: clinicopathologic analysis of 13 cases.

Eleanor Chen1, Christopher D M Fletcher.   

Abstract

Cellular angiofibroma is a mesenchymal neoplasm that is characterized by a bland spindle cell component, morphologically reminiscent of spindle cell lipoma, and thick-walled vessels. The tumor occurs equally in men and women and usually arises in the inguino-scrotal or vulvovaginal regions. An earlier study of 51 cases from our group showed that the tumor follows a benign course without any tendency for recurrence. In 1 case, an intralesional microscopic nodule of pleomorphic liposarcoma was observed. The biologic significance of atypia or sarcomatous transformation in cellular angiofibroma remains uncertain. In this study, we characterized clinicopathologic features in 13 cases of cellular angiofibroma with morphologic atypia or sarcomatous transformation. Thirteen cases with atypia or sarcomatous transformation among 154 usual cellular angiofibromas identified between 1993 and 2009 were retrieved from consultation files. There were 12 females and 1 male ranging in age from 39 to 71 years (median age, 46 y). Tumor size ranged from 1.2 to 7.5 cm. In 11 cases, the tumors occurred in the vulva. One case each occurred in the paratesticular and hip regions. Most tumors were located in subcutaneous tissue. There were 4 cases of cellular angiofibroma with atypia. Three showed severely atypical cells as scattered foci within the cellular angiofibroma. One case showed a discrete nodule of atypical cells. There were 9 cases of cellular angiofibroma with morphologic features of sarcomatous transformation. In each case, abrupt transition to a discrete sarcomatous component was seen. Of these 9 cases, the sarcomatous component in 2 cases showed features of pleomorphic liposarcoma with multivacuolated lipoblasts readily identified. Three of these 9 cases showed discrete nodule(s) closely resembling atypical lipomatous tumor within usual cellular angiofibroma. In the remaining 4 cases, the sarcomatous component was composed of pleomorphic spindle cells arranged in various patterns. By immunohistochemistry, atypical cells and sarcomatous areas showed either multifocal or more diffuse p16 expression compared with either scattered or negative expression in the conventional cellular angiofibroma. The 3 cases with atypical lipomatous tumor-like areas were negative for MDM-2 and CDK4. Follow-up information was available for 7 patients (range from 2 to 75 mo; median: 14 mo). Six patients did not develop recurrence or metastasis. One patient died of metastatic carcinoma of unknown primary site 27 months after the diagnosis of cellular angiofibroma with sarcomatous transformation. Cellular angiofibroma with atypia or morphologic sarcomatous transformation occurs predominantly in the subcutaneous tissue of the vulva and, as yet, shows no evident tendency to recur based on limited clinical follow-up available for 7 cases. The sarcomatous component can show variable features including atypical lipomatous tumor, pleomorphic liposarcoma, and pleomorphic sarcoma NOS. Overexpression of p16 in the atypical cells and sarcomatous component suggests a possible underlying molecular mechanism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20305534     DOI: 10.1097/PAS.0b013e3181d74bdb

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  15 in total

1.  A large cellular angiofibroma of the male pelvis presenting with obstructive voiding: A case report and review of the literature.

Authors:  Justin B Emtage; Justin Parker; Jorge E Marcet; Jon Finan; Jorge L Lockhart; David J Hernandez
Journal:  Can Urol Assoc J       Date:  2013 May-Jun       Impact factor: 1.862

2.  Cellular angiofibroma: two case reports of a rare vulvar tumor.

Authors:  Vinod Priyadarshi; Nidhi Sehgal; Sanjay Kumar Gupta; Vijoy Kumar; Mahendra Singh
Journal:  J Obstet Gynaecol India       Date:  2012-11-06

3.  Double Para-testicular Cellular Angiofibroma and Synchronous Testicular Microlithiasis.

Authors:  Seungkoo Lee; Hyuck Jae Choi
Journal:  J Pathol Transl Med       Date:  2015-07-29

4.  Re-evaluating tumors of purported specialized prostatic stromal origin reveals molecular heterogeneity, including non-recurring gene fusions characteristic of uterine and soft tissue sarcoma subtypes.

Authors:  Andres M Acosta; Lynette M Sholl; Brendan C Dickson; Jesse K McKenney; Jennifer B Gordetsky; Michael R Pins; Adrian Marino-Enriquez; Fei Dong; Adrian M Dubuc; Paola Dal Cin; Christopher D M Fletcher
Journal:  Mod Pathol       Date:  2021-05-13       Impact factor: 7.842

5.  Superficial CD34-positive Fibroblastic Tumour: Unique Subungual Presentation with Confounding Clinical Findings Resembling Fibrokeratoma-like Bowen's Disease.

Authors:  Christophe Perrin; Florence Pedeutour; Bérengère Dadone-Montaudié; Damien Ambrosetti
Journal:  Acta Derm Venereol       Date:  2021-02-11       Impact factor: 3.875

Review 6.  Cellular angiofibroma in women: a review of the literature.

Authors:  Vincenzo Dario Mandato; Susanna Santagni; Alberto Cavazza; Lorenzo Aguzzoli; Martino Abrate; Giovanni Battista La Sala
Journal:  Diagn Pathol       Date:  2015-07-19       Impact factor: 2.644

7.  Cellular angiofibroma of the vulva: a poorly known entity, a case report and literature review.

Authors:  Mouna Khmou; Najat Lamalmi; Abderrahmane Malihy; Lamia Rouas; Zaitouna Alhamany
Journal:  BMC Clin Pathol       Date:  2016-06-04

8.  A rare cellular angiofibroma of the epididymis.

Authors:  Qiang Guo; Jian-Dong Zhang; Li Li; Jian-Ping Xie; Ding Ma; Yan-Gang Zhang
Journal:  Asian J Androl       Date:  2018 Jan-Feb       Impact factor: 3.285

9.  A Giant Vulvar Mass: A Case Study of Cellular Angiofibroma.

Authors:  Ümit Aydın; Hasan Terzi; Ünal Turkay; Ahmet Tuğrul Eruyar; Ahmet Kale
Journal:  Case Rep Obstet Gynecol       Date:  2016-05-16

10.  Cervicovaginal cellular angiofibroma.

Authors:  Sarah Van Mulders; Ellen Faes; Glenn Broeckx; Yves Jacquemyn
Journal:  BMJ Case Rep       Date:  2020-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.